Pacb stock price target

Get the latest Pacific Biosciences of Californ (PACB) stock news and And analysts still expect the Takeaway.com-Just Eat deal to complete, albeit with a slight  Pacific Biosciences of California Stock Price Forecast, PACB stock price prediction. The best long-term & short-term Pacific Biosciences of California share price 

Pacific Biosciences of California Inc. Research & Ratings ... Apr 03, 2020 · View today's stock price, news and analysis for Pacific Biosciences of California Inc. (PACB). Barron's also provides information on historical stock ratings, target prices, company earnings PACB Stock News - Fidelity Apr 03, 2020 · Pacific Biosciences of California, Inc. (PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that Michael Phillips has decided to retire from his role as the company s Senior Vice President of Research and Development as of …

Find the latest Pacific Biosciences of Californ (PACB) stock quote, history, news and other vital NasdaqGS - NasdaqGS Real Time Price. 1y Target Est, 5.75 

See Pacific Biosciences of Californ (PACB) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Pacific Biosciences of California, Inc. PACB ... - Benzinga Jan 01, 2010 · Pacific Biosciences of California, Inc. (NASDAQ: PACB) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings Pacific Biosciences of California Inc. [PACB] stock ... 12 days ago · Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PACB shares is $6.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PACB stock is a recommendation set at 2.40. Pacific Biosciences Of California, Inc. - PACB - Stock ...

Mar 05, 2020 · PACB stock construct a change of 10.92 in a total of its share price and finished its trading at 3.86. Pacific Biosciences of California, Inc. institutional ownership is held at 85.20% while insider ownership was 2.30%.

PACB Price Target and Analyst Ratings (Pacific Biosciences ... Nov 06, 2019 · Their average twelve-month price target is $7.50, suggesting that the stock has a possible upside of 34.65%. The high price target for PACB is $8.00 and the low price target for PACB is $6.50. There are currently 3 hold ratings for the stock, resulting in a consensus rating of "Hold.". PACB | Pacific Biosciences of California Inc. Analyst ...

PACB - Pacific Biosciences Stock Analyst Ratings ...

Here’s Why Pacific Biosciences of California, Inc. (PACB ... Mar 03, 2020 · On Monday, shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB) marked $3.44 per share versus a previous $3.40 closing price. With having a 1.18% gain, an insight into the fundamental values of Pacific Biosciences of California, Inc., investors would also find a great ally in the technical patterns of the stock movements showed in stock charts.

PACB Price Target - ETF Channel

Stock analysis for Pacific Biosciences of California Inc (PACB:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and 

Average Target Price: $5.67 Brokerage Recommendations. stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices PACIFIC BIOSCIENCES OF CALIFORNIA, INC. : PACB Stock Price ... Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. Analysts Turn Mixed On Livongo Health Inc. (NASDAQ:LVGO ... 7 days ago · Their price target on the stock stands at $5. Piper Jaffray also rated PACB as Upgrade on October 15, 2019, with its price target of $8 suggesting that …